L
Lori J. Sokoll
Researcher at Johns Hopkins University School of Medicine
Publications - 254
Citations - 16348
Lori J. Sokoll is an academic researcher from Johns Hopkins University School of Medicine. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 57, co-authored 237 publications receiving 14165 citations. Previous affiliations of Lori J. Sokoll include Johns Hopkins University & Technische Universität München.
Papers
More filters
Journal ArticleDOI
Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer
Zhen Zhang,Robert C. Bast,Yinhua Yu,Jinong Li,Lori J. Sokoll,Alex J. Rai,Jason M. Rosenzweig,Bonnie Cameron,Young Y. Wang,Xiao Ying Meng,Andrew Berchuck,Carolien van Haaften-Day,Neville F. Hacker,Henk W.A. de Bruijn,Ate G.J. van der Zee,Ian Jacobs,Eric T. Fung,Daniel W. Chan +17 more
TL;DR: These biomarkers demonstrated the potential to improve the detection of early stage ovarian cancer by demonstrating the sensitivity and specificity of a multivariate model combining the three biomarkers.
Journal ArticleDOI
Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
Hui Zhang,Tao Liu,Zhen Zhang,Samuel H. Payne,Bai Zhang,Jason E. McDermott,Jian-Ying Zhou,Vladislav A. Petyuk,Li Chen,Debjit Ray,Shisheng Sun,Feng Yang,Lijun Chen,Jing Wang,Punit Shah,Seong Won Cha,Paul Aiyetan,Sunghee Woo,Yuan Tian,Marina A. Gritsenko,Therese R. W. Clauss,Caitlin H. Choi,Matthew E. Monroe,Stefani N. Thomas,Song Nie,Chaochao Wu,Ronald J. Moore,Kun-Hsing Yu,David L. Tabb,David Fenyö,Vineet Bafna,Yue Wang,Henry Rodriguez,Emily S. Boja,Tara Hiltke,Robert Rivers,Lori J. Sokoll,Heng Zhu,Ie Ming Shih,Leslie Cope,Akhilesh Pandey,Bing Zhang,Michael Snyder,Douglas A. Levine,Richard D. Smith,Daniel W. Chan,Karin D. Rodland,Steven A. Carr,Michael A. Gillette,Karl R. Klauser,Eric Kuhn,D. R. Mani,Philipp Mertins,Karen A. Ketchum,Ratna R. Thangudu,Shuang Cai,Mauricio Oberti,Amanda G. Paulovich,Jeffrey R. Whiteaker,Nathan Edwards,Peter B. McGarvey,Subha Madhavan,Pei Wang,Gordon Whiteley,Steven J. Skates,Forest M. White,Christopher R. Kinsinger,Mehdi Mesri,Kenna M. Shaw,Stephen E. Stein,Paul A. Rudnick,Michael Snyder,Yingming Zhao,Xian Chen,David F. Ransohoff,Andrew N. Hoofnagle,Daniel C. Liebler,Melinda E. Sanders,Zhiao Shi,Robbert J.C. Slebos,Lisa J. Zimmerman,Sherri R. Davies,Li Ding,Matthew J. Ellis,R. Reid Townsend +84 more
TL;DR: A view of how the somatic genome drives the cancer proteome and associations between protein and post-translational modification levels and clinical outcomes in HGSC is provided.
Journal ArticleDOI
Immunosensors--principles and applications to clinical chemistry.
TL;DR: Clinical chemists should take advantage of immunosensors in clinical diagnostics as the future role of this technique in intralaboratory, as well as bedside testing, will become even more important as the clinical laboratory is faced with increasing pressure to contain costs.
Journal ArticleDOI
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
Catharine M. Sturgeon,Michael J. Duffy,Ulf-Håkan Stenman,Hans Lilja,Nils Brünner,Daniel W. Chan,Richard J. Babaian,Robert C. Bast,Barry L. Dowell,Francisco J. Esteva,Caj Haglund,Nadia Harbeck,Daniel F. Hayes,Mads Nikolaj Holten-Andersen,George G. Klee,Rolf Lamerz,Leendert H. J. Looijenga,Rafael Molina,Hans Jørgen Nielsen,Harry G. Rittenhouse,Axel Semjonow,Ie Ming Shih,Paul Sibley,György Sölétormos,Carsten Stephan,Lori J. Sokoll,Barry Hoffman,Eleftherios P. Diamandis +27 more
TL;DR: Recommendations to encourage optimal use of tumor markers for 5 cancer sites were critically reviewed and alpha-fetoprotein, human chorionic gonadotropin, and lactate dehydrogenase are recommended for diagnosis/case finding, staging, prognosis determination, recurrence detection, and therapy monitoring.
Journal ArticleDOI
Effect of Vitamin D Supplementation on Wintertime and Overall Bone Loss in Healthy Postmenopausal Women
Bess Dawson-Hughes,Gerard E. Dallal,Elizabeth A. Krall,Susan S. Harris,Lori J. Sokoll,Gladys Falconer +5 more
TL;DR: At latitude 42 degrees, healthy postmenopausal women with vitamin D intakes of 100 IU daily can significantly reduce late wintertime bone loss and improve net bone density of the spine over one year by increasing their intake of vitamin D to 500 IU daily.